+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Single amino acid substitution (840Arg-->His) in the hormone-binding domain of the androgen receptor leads to incomplete androgen insensitivity syndrome associated with a thermolabile androgen receptor



Single amino acid substitution (840Arg-->His) in the hormone-binding domain of the androgen receptor leads to incomplete androgen insensitivity syndrome associated with a thermolabile androgen receptor



European Journal of Endocrinology 130(6): 569-574



We have characterized the androgen receptor in a Japanese girl and her maternal cousin in a family with incomplete androgen insensitivity syndrome, and have investigated the molecular basis. Whole-cell androgen binding assay in cultured genital skin fibroblasts from both patients showed a normal maximum binding capacity and a normal apparent dissociation constant. However, androgen binding in fibroblasts from both patients decreased to 30% when the assay temperature was raised from 30 degrees C to 41 degrees C, indicating the presence of the thermolability of ligand binding to the androgen receptor. Sequence analysis of the coding exons of the androgen receptor gene from the patients revealed a single nucleotide substitution at position 2881 in exon G, resulting in the conversion of arginine (CGT) to histidine (CAT) at amino acid position 840 in the hormone-binding domain of the androgen receptor. The family study showed that the mothers and the maternal grandmother of the patients are heterozygous carriers for this mutation, whereas the father does not carry it, supporting the view that androgen insensitivity syndrome is an X chromosome-linked disorder. The single amino acid substitution may explain the qualitative abnormality of the androgen receptor displaying thermolability, which is thought to be the pathogenesis of incomplete androgen insensitivity syndrome in the patients.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 047375525

Download citation: RISBibTeXText

PMID: 8205256


Related references

Single amino acid substitution (840Arg -> His) in the hormone-binding domain of the androgen receptor leads to incomplete androgen insensitivity syndrome associated with a thermolabile androgen receptor. European Journal of Endocrinology 130(6): 569-574, 1994

A single amino acid substitution (Met786----Val) in the steroid-binding domain of human androgen receptor leads to complete androgen insensitivity syndrome. Journal of Clinical Endocrinology and Metabolism 74(5): 1152-1157, 1992

Androgen insensitivity due to amino acid substitutions at 4 of 14 positions in an ultra conserved region of the androgen binding domain of the human androgen receptor. Clinical & Investigative Medicine 15(4 Suppl.): A40, 1992

Single amino acid substitutions at 2 of 14 positions in an ultraconserved region of the androgen receptor yield an androgen-binding domain that is reversibly thermolabile. American Journal of Human Genetics 55(3 Suppl. ): A178, 1994

Mild androgen insensitivity and male infertility Substitution in the ligand-binding domain of the androgen receptor that impairs transactivation but not androgen binding. American Journal of Human Genetics 59(4 Suppl. ): A43, 1996

A single amino acid substitution (gly743 --> val) in the steroid-binding domain of the human androgen receptor leads to Reifenstein syndrome. Journal of Clinical Endocrinology and Metabolism 77(1): 103-107, 1993

Premature termination mutation (772Glu-->stop) in the hormone-binding domain of the androgen receptor in a patient with the receptor-negative form of complete androgen insensitivity syndrome. Endocrine Journal 42(5): 643-648, 1995

Partial androgen insensitivity caused by an androgen receptor mutation at amino acid 907 (Gly-->Arg) that results in decreased ligand binding affinity and reduced androgen receptor messenger ribonucleic acid levels. Journal of Clinical Endocrinology and Metabolism 81(1): 236-243, 1996

Response to androgen treatment in a patient with partial androgen insensitivity and a mutation in the deoxyribonucleic acid-binding domain of the androgen receptor. Journal of Clinical Endocrinology and Metabolism 83(4): 1173-1176, 1998

A novel point mutation in the hormone binding domain of the androgen receptor associated with partial and minimal androgen insensitivity syndrome. Journal of Pediatric Endocrinology and Metabolism 16(2): 149-154, 2003

A mutation c.C2812T in the androgen receptor gene resulting in Pro817Leu substitution may affect dimerization of the androgen receptor and result in androgen insensitivity syndrome. Fertility and Sterility 85(6): 1822.E1-4, 2006

Human androgen insensitivity due to point mutations encoding amino acid substitutions in the androgen receptor steroid-binding domain. Human Mutation 6(2): 152-162, 1995

Functional and Structural Study of the Amino Acid Substitution in a Novel Familial Androgen Receptor Mutation (W752G) Responsible for Complete Androgen Insensitivity Syndrome. Sexual Development 2018:, 2018

A point mutation in the second zinc finger of the DNA-binding domain of the androgen receptor gene causes complete androgen insensitivity in two siblings with receptor-positive androgen resistance. Molecular Endocrinology 7(7): 861-869, 1993

A new mutation within the deoxyribonucleic acid-binding domain of the androgen receptor gene in a family with complete androgen insensitivity syndrome. Fertility and Sterility 60(5): 814-819, 1993